Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Cerebrospinal Fluid Removal for Idiopathic Intracranial Hypertension: Less Cerebrospinal Fluid Is Best.

Perloff MD, Parikh SK, Fiorito-Torres F, McAdams MT, Rayhill ML.

J Neuroophthalmol. 2019 Feb 18. doi: 10.1097/WNO.0000000000000759. [Epub ahead of print]

PMID:
30801442
2.

Radicular Pain Syndromes: Cervical, Lumbar, and Spinal Stenosis.

Patel EA, Perloff MD.

Semin Neurol. 2018 Dec;38(6):634-639. doi: 10.1055/s-0038-1673680. Epub 2018 Dec 6. Review.

PMID:
30522138
3.

The Simplified Epiduralysis After Laminectomy/Fusion (SEAL) Procedure for Postsurgical Radicular Low Back Pain.

Perloff MD, Dashkoff J, Ge G.

Pain Med. 2019 Mar 1;20(3):578-580. doi: 10.1093/pm/pny195. No abstract available.

PMID:
30307575
4.

Urgent care peripheral nerve blocks for refractory trigeminal neuralgia.

Perloff MD, Chung JS.

Am J Emerg Med. 2018 Nov;36(11):2058-2060. doi: 10.1016/j.ajem.2018.08.019. Epub 2018 Aug 8.

PMID:
30119988
5.

Cerebellar stroke presenting with isolated dizziness: Brain MRI in 136 patients.

Perloff MD, Patel NS, Kase CS, Oza AU, Voetsch B, Romero JR.

Am J Emerg Med. 2017 Nov;35(11):1724-1729. doi: 10.1016/j.ajem.2017.06.034. Epub 2017 Jun 22.

PMID:
28687453
6.

Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men.

Marshall JR, Burk RF, Payne Ondracek R, Hill KE, Perloff M, Davis W, Pili R, George S, Bergan R.

Oncotarget. 2017 Apr 18;8(16):26312-26322. doi: 10.18632/oncotarget.15460.

7.

Triptans and migraine: advances in use, administration, formulation, and development.

Macone AE, Perloff MD.

Expert Opin Pharmacother. 2017 Mar;18(4):387-397. doi: 10.1080/14656566.2017.1288721. Epub 2017 Feb 14. Review.

PMID:
28129702
8.

Physical Medicine and Rehabilitation: The Changing Landscape of Residency and Career.

Barrette KF, Perloff MD.

Am J Phys Med Rehabil. 2017 Feb;96(2):131-132. doi: 10.1097/PHM.0000000000000556. No abstract available.

PMID:
27386807
9.

Zika virus-associated Guillain-Barré syndrome variant in Haiti.

Kassavetis P, Joseph JM, Francois R, Perloff MD, Berkowitz AL.

Neurology. 2016 Jul 19;87(3):336-7. doi: 10.1212/WNL.0000000000002759. Epub 2016 May 6. No abstract available.

PMID:
27164708
10.

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.

Mullooly M, Pfeiffer RM, Nyante SJ, Heckman-Stoddard BM, Perloff M, Jatoi I, Brinton LA, Aiello Bowles EJ, Hoover RN, Glass A, Berrington de Gonzalez A, Sherman ME, Gierach GL.

J Clin Oncol. 2016 Jun 20;34(18):2093-7. doi: 10.1200/JCO.2015.64.4492. Epub 2016 Mar 28. No abstract available.

11.

Epidural Glucocorticoid Injections for Spinal Stenosis, Interlaminal at the Worst Level.

Savino AK, Perloff MD.

Pain Med. 2016 Feb;17(2):373-4. doi: 10.1111/pm/pme.12901. No abstract available.

PMID:
26893463
12.

Gabapentin Therapy in Psychiatric Disorders: A Systematic Review.

Berlin RK, Butler PM, Perloff MD.

Prim Care Companion CNS Disord. 2015 Oct 22;17(5). doi: 10.4088/PCC.15r01821. eCollection 2015.

13.

Double-Blind, Randomized Trial of Alternative Letrozole Dosing Regimens in Postmenopausal Women with Increased Breast Cancer Risk.

López AM, Pruthi S, Boughey JC, Perloff M, Hsu CH, Lang JE, Ley M, Frank D, Taverna JA, Chow HH.

Cancer Prev Res (Phila). 2016 Feb;9(2):142-8. doi: 10.1158/1940-6207.CAPR-15-0322. Epub 2015 Dec 14.

14.

Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus.

Joe AK, Schnoll-Sussman F, Bresalier RS, Abrams JA, Hibshoosh H, Cheung K, Friedman RA, Yang CS, Milne GL, Liu DD, Lee JJ, Abdul K, Bigg M, Foreman J, Su T, Wang X, Ahmed A, Neugut AI, Akpa E, Lippman SM, Perloff M, Brown PH, Lightdale CJ.

Cancer Prev Res (Phila). 2015 Dec;8(12):1131-7. doi: 10.1158/1940-6207.CAPR-14-0274-T. Epub 2015 Oct 15.

15.

Gabapentin in Headache Disorders: What Is the Evidence?

Perloff MD, Berlin RK, Gillette M, Petersile MJ, Kurowski D.

Pain Med. 2016 Jan;17(1):162-71.

PMID:
26398728
16.

No Pain, No Pigment.

Fiorito-Torres F, Murphy DN, Perloff MD.

Am J Phys Med Rehabil. 2016 Jan;95(1):e9. doi: 10.1097/PHM.0000000000000385. No abstract available.

PMID:
26368838
17.

Practical considerations in opioid use for brain neoplasm.

Perloff MD.

Continuum (Minneap Minn). 2015 Apr;21(2 Neuro-oncology):480-6. doi: 10.1212/01.CON.0000464183.35322.5f.

PMID:
25837908
18.

25% cluster.

Perloff MD, Lee S.

Cephalalgia. 2015 Jun;35(7):635. doi: 10.1177/0333102414544981. Epub 2014 Aug 8. No abstract available.

PMID:
25106662
19.

TIA for the internist.

Zhu S, Perloff MD.

Am J Med. 2014 Oct;127(10):901-2. doi: 10.1016/j.amjmed.2014.06.024. Epub 2014 Jul 2. No abstract available.

PMID:
24997414
20.

Beyond neuropathic pain: gabapentin use in cancer pain and perioperative pain.

Yan PZ, Butler PM, Kurowski D, Perloff MD.

Clin J Pain. 2014 Jul;30(7):613-29. doi: 10.1097/AJP.0000000000000014. Review.

PMID:
24281281
21.

Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.

Armstrong WB, Taylor TH, Kennedy AR, Melrose RJ, Messadi DV, Gu M, Le AD, Perloff M, Civantos F, Goodwin WJ, Wirth LJ, Kerr AR, Meyskens FL Jr.

Cancer Prev Res (Phila). 2013 May;6(5):410-8. doi: 10.1158/1940-6207.CAPR-13-0004.

22.

Early-phase development of cancer prevention agents: challenges and opportunities.

Perloff M, Steele VE.

Cancer Prev Res (Phila). 2013 May;6(5):379-83. doi: 10.1158/1940-6207.CAPR-12-0463. Epub 2013 Mar 6.

23.

Clinical Reasoning: a 54-year-old man with unilateral weakness and vascular risk factors.

Lioutas V, Romero JR, Kleinman MS, Wang JW, Perloff MD.

Neurology. 2012 Jul 24;79(4):e28-32. doi: 10.1212/WNL.0b013e318260435a. No abstract available.

24.

Constructional apraxia reversed with methylprednisolone.

Westwood AJ, Perloff MD, McGeeney BE, Seshadri S.

J Neuropsychiatry Clin Neurosci. 2012 Spring;24(2):E51-2. doi: 10.1176/appi.neuropsych.11060136. No abstract available.

PMID:
22772706
25.

Gabapentin use in the prevention of succinylcholine-induced fasciculation and myalgia.

Rayhill ML, Perloff MD.

J Postgrad Med. 2012 Jan-Mar;58(1):1-2. doi: 10.4103/0022-3859.93244. No abstract available.

26.

Writing from the wards: advice for residents.

Perloff MD, Zuzuárregui JR, Frank SA.

Neurologist. 2012 Mar;18(2):96-8. doi: 10.1097/NRL.0b013e31823fa3d0.

PMID:
22367840
27.

Interlaminar versus transforaminal epidural steroids for the treatment of subacute lumbar radicular pain: a randomized, blinded, prospective outcome study.

Gharibo CG, Varlotta GP, Rhame EE, Liu EC, Bendo JA, Perloff MD.

Pain Physician. 2011 Nov-Dec;14(6):499-511.

28.

Methyl selenocysteine: single-dose pharmacokinetics in men.

Marshall JR, Ip C, Romano K, Fetterly G, Fakih M, Jovanovic B, Perloff M, Crowell J, Davis W, French-Christy R, Dew A, Coomes M, Bergan R.

Cancer Prev Res (Phila). 2011 Nov;4(11):1938-44. doi: 10.1158/1940-6207.CAPR-10-0259. Epub 2011 Aug 16.

29.

Anorgasmia with gabapentin may be common in older patients.

Perloff MD, Thaler DE, Otis JA.

Am J Geriatr Pharmacother. 2011 Jun;9(3):199-203. doi: 10.1016/j.amjopharm.2011.04.007. Epub 2011 May 23.

PMID:
21602106
30.

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668.

Reid JM, Walden CA, Qin R, Ziegler KL, Haslam JL, Rajewski RA, Warndahl R, Fitting CL, Boring D, Szabo E, Crowell J, Perloff M, Jong L, Bauer BA, Mandrekar SJ, Ames MM, Limburg PJ; Cancer Prevention Network.

Cancer Prev Res (Phila). 2011 Mar;4(3):347-53. doi: 10.1158/1940-6207.CAPR-10-0313.

31.

Suspecting optic neuritis, diagnosing Bartonella cat scratch disease.

Gan JJ, Mandell AM, Otis JA, Holmuhamedova M, Perloff MD.

Arch Neurol. 2011 Jan;68(1):122-6. doi: 10.1001/archneurol.2010.345.

PMID:
21220684
32.

Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer.

Bishayee A, Ahmed S, Brankov N, Perloff M.

Front Biosci (Landmark Ed). 2011 Jan 1;16:980-96. Review.

33.

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.

Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE.

Cancer Res. 2010 Nov 15;70(22):9003-11. doi: 10.1158/0008-5472.CAN-10-2364. Epub 2010 Oct 8.

34.

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K.

Cancer Res. 2010 Oct 1;70(19):7392-9. doi: 10.1158/0008-5472.CAN-10-2027. Epub 2010 Sep 14.

35.

Teaching video neuroimages: the elusive L5 reflex.

Perloff MD, Leroy AM, Ensrud ER.

Neurology. 2010 Sep 14;75(11):e50. doi: 10.1212/WNL.0b013e3181f25ea6. No abstract available.

PMID:
20837959
36.

Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.

Chow HH, Garland LL, Hsu CH, Vining DR, Chew WM, Miller JA, Perloff M, Crowell JA, Alberts DS.

Cancer Prev Res (Phila). 2010 Sep;3(9):1168-75. doi: 10.1158/1940-6207.CAPR-09-0155. Epub 2010 Aug 17.

37.

Iatrogenic hyperammonemia after anorexia.

Welsh E, Kucera J, Perloff MD.

Arch Intern Med. 2010 Mar 8;170(5):486-8. doi: 10.1001/archinternmed.2009.549.

PMID:
20212188
38.

Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells.

Perloff MD, von Moltke LL, Fahey JM, Greenblatt DJ.

J Pharm Pharmacol. 2007 Jul;59(7):947-53.

PMID:
17637189
39.

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.

Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52.

40.

Safety and efficacy of weekly oral oltipraz in chronic smokers.

Kelley MJ, Glaser EM, Herndon JE 2nd, Becker F, Bhagat R, Zhang YJ, Santella RM, Carmella SG, Hecht SS, Gallot L, Schilder L, Crowell JA, Perloff M, Folz RJ, Bergan RC.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):892-9.

41.

Interactions of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen with P-glycoprotein and CYP3A.

Bekaii-Saab TS, Perloff MD, Weemhoff JL, Greenblatt DJ, von Moltke LL.

Biopharm Drug Dispos. 2004 Oct;25(7):283-9.

PMID:
15386482
42.

Interaction of triazolam and ketoconazole in P-glycoprotein-deficient mice.

von Moltke LL, Granda BW, Grassi JM, Perloff MD, Vishnuvardhan D, Greenblatt DJ.

Drug Metab Dispos. 2004 Aug;32(8):800-4.

PMID:
15258104
43.

Coronary artery bypass: a user's manual.

Perloff JK, Perloff M.

Am J Cardiol. 2004 Jul 15;94(2):172-7. No abstract available.

PMID:
15246894
44.

Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats.

Perloff MD, von Moltke LL, Greenblatt DJ.

Xenobiotica. 2004 Feb;34(2):133-50.

PMID:
14985144
45.

Fenretinide: a prototype cancer prevention drug.

Malone W, Perloff M, Crowell J, Sigman C, Higley H.

Expert Opin Investig Drugs. 2003 Nov;12(11):1829-42. Review.

PMID:
14585058
46.

Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.

Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F.

Clin Cancer Res. 2003 Oct 15;9(13):4722-9.

47.

Rapid assessment of P-glycoprotein inhibition and induction in vitro.

Perloff MD, Störmer E, von Moltke LL, Greenblatt DJ.

Pharm Res. 2003 Aug;20(8):1177-83.

PMID:
12948015
48.
49.

Effect of zolpidem on human cytochrome P450 activity, and on transport mediated by P-glycoprotein.

von Moltke LL, Weemhoff JL, Perloff MD, Hesse LM, Harmatz JS, Roth-Schechter BF, Greenblatt DJ.

Biopharm Drug Dispos. 2002 Dec;23(9):361-7.

PMID:
12469329
50.

Fexofenadine transport in Caco-2 cells: inhibition with verapamil and ritonavir.

Perloff MD, von Moltke LL, Greenblatt DJ.

J Clin Pharmacol. 2002 Nov;42(11):1269-74.

PMID:
12412827

Supplemental Content

Loading ...
Support Center